| 1 | The regulation of cyclin D1 degradation: roles in cancer dev… (10.1186/1476-4598-6-24) | Abstract References ORCID License | 283.63 | 685 |
| 2 | — (10.1186/1476-4598-5-29) | Abstract References ORCID License | 280.62 | 639 |
| 3 | — (10.1186/1476-4598-5-24) | Abstract References ORCID License | 274.97 | 561 |
| 4 | OncomiRs: the discovery and progress of microRNAs in cancers (10.1186/1476-4598-6-60) | Abstract References ORCID License | 273.24 | 539 |
| 5 | — (10.1186/1476-4598-1-9) | Abstract References ORCID License | 266.37 | 460 |
| 6 | — (10.1186/1476-4598-2-29) | Abstract References ORCID License | 263.25 | 428 |
| 7 | The complexity of NF-κB signaling in inflammation and cancer (10.1186/1476-4598-12-86) | Abstract ORCID License | 258.56 | 2801 |
| 8 | Altered regulation of metabolic pathways in human lung cance… (10.1186/1476-4598-8-41) | Abstract References ORCID License | 258.43 | 383 |
| 9 | Serum microRNAs as non-invasive biomarkers for cancer (10.1186/1476-4598-9-306) | Abstract References ORCID License | 254.41 | 349 |
| 10 | — (10.1186/1476-4598-3-29) | Abstract References ORCID License | 254.16 | 347 |
| 11 | — (10.1186/1476-4598-5-17) | Abstract References ORCID License | 252.11 | 331 |
| 12 | Predictive value of progression-related gene classifier in p… (10.1186/1476-4598-9-3) | Abstract References ORCID License | 251.05 | 323 |
| 13 | MicroRNAs in colorectal cancer: translation of molecular bio… (10.1186/1476-4598-8-102) | Abstract References ORCID License | 244.40 | 277 |
| 14 | Metabolite profiling of human colon carcinoma – deregulation… (10.1186/1476-4598-7-72) | Abstract References ORCID License | 243.14 | 269 |
| 15 | Convergence between Wnt-β-catenin and EGFR signaling in canc… (10.1186/1476-4598-9-236) | Abstract References ORCID License | 238.20 | 240 |
| 16 | Survival signalling and apoptosis resistance in glioblastoma… (10.1186/1476-4598-9-135) | Abstract References ORCID License | 235.98 | 228 |
| 17 | — (10.1186/1476-4598-2-1) | Abstract References ORCID License | 234.64 | 221 |
| 18 | The functional role of long non-coding RNA in human carcinom… (10.1186/1476-4598-10-38) | Abstract ORCID License | 232.29 | 1250 |
| 19 | Molecular detection, quantification, and isolation of Strept… (10.1186/1476-4598-9-249) | Abstract References ORCID License | 231.18 | 204 |
| 20 | CircRNA: functions and properties of a novel potential bioma… (10.1186/s12943-017-0663-2) | Abstract ORCID License | 230.20 | 1172 |
| 21 | Tumor glycolysis as a target for cancer therapy: progress an… (10.1186/1476-4598-12-152) | Abstract ORCID License | 229.97 | 1164 |
| 22 | — (10.1186/1476-4598-1-2) | Abstract References ORCID License | 229.89 | 198 |
| 23 | — (10.1186/1476-4598-6-1) | Abstract References ORCID License | 229.67 | 197 |
| 24 | Kinase-targeted cancer therapies: progress, challenges and f… (10.1186/s12943-018-0804-2) | Abstract ORCID License | 228.75 | 1121 |
| 25 | Improvement of different vaccine delivery systems for cancer… (10.1186/1476-4598-10-3) | Abstract References ORCID License | 228.10 | 190 |
| 26 | Contribution of oncoproteomics to cancer biomarker discovery (10.1186/1476-4598-6-25) | Abstract References ORCID License | 226.48 | 183 |
| 27 | — (10.1186/1476-4598-2-24) | Abstract References ORCID License | 226.01 | 181 |
| 28 | — (10.1186/1476-4598-2-14) | Abstract References ORCID License | 225.77 | 180 |
| 29 | Tumor cell behaviour modulation by mesenchymal stromal cells (10.1186/1476-4598-9-129) | Abstract References ORCID License | 223.30 | 170 |
| 30 | — (10.1186/1476-4598-2-23) | Abstract References ORCID License | 223.04 | 169 |
| 31 | Radiation-induced caveolin-1 associated EGFR internalization… (10.1186/1476-4598-7-69) | Abstract References ORCID License | 222.27 | 166 |
| 32 | — (10.1186/1476-4598-2-4) | Abstract References ORCID License | 221.22 | 162 |
| 33 | Sorafenib blocks tumour growth, angiogenesis and metastatic… (10.1186/1476-4598-8-118) | Abstract References ORCID License | 221.22 | 162 |
| 34 | Identification of early molecular markers for breast cancer (10.1186/1476-4598-10-15) | Abstract References ORCID License | 218.47 | 152 |
| 35 | Glucosylceramide synthase upregulates MDR1 expression in the… (10.1186/1476-4598-9-145) | Abstract References ORCID License | 217.90 | 150 |
| 36 | Glycogen synthase kinase 3 beta: can it be a target for oral… (10.1186/1476-4598-9-144) | Abstract References ORCID License | 217.61 | 149 |
| 37 | — (10.1186/1476-4598-2-8) | Abstract References ORCID License | 216.44 | 145 |
| 38 | — (10.1186/1476-4598-2-41) | Abstract References ORCID License | 215.53 | 142 |
| 39 | Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-… (10.1186/1476-4598-6-71) | Abstract References ORCID License | 215.53 | 142 |
| 40 | Lnc RNA HOTAIR functions as a competing endogenous RNA to re… (10.1186/1476-4598-13-92) | Abstract ORCID License | 215.50 | 746 |
| 41 | Runx2 transcriptome of prostate cancer cells: insights into… (10.1186/1476-4598-9-258) | Abstract References ORCID License | 215.23 | 141 |
| 42 | — (10.1186/1476-4598-4-18) | Abstract References ORCID License | 214.61 | 139 |
| 43 | A novel small molecule inhibits STAT3 phosphorylation and DN… (10.1186/1476-4598-9-217) | Abstract References ORCID License | 213.67 | 136 |
| 44 | Wnt-11 promotes neuroendocrine-like differentiation, surviva… (10.1186/1476-4598-9-55) | Abstract References ORCID License | 213.35 | 135 |
| 45 | Regulation of epithelial-mesenchymal transition through epig… (10.1186/s12943-016-0502-x) | Abstract ORCID License | 212.58 | 682 |
| 46 | — (10.1186/1476-4598-2-12) | Abstract References ORCID License | 212.39 | 132 |
| 47 | ALDH isozymes downregulation affects cell growth, cell motil… (10.1186/1476-4598-7-87) | Abstract References ORCID License | 212.39 | 132 |
| 48 | — (10.1186/1476-4598-5-60) | Abstract References ORCID License | 211.39 | 129 |
| 49 | ROS signaling under metabolic stress: cross-talk between AMP… (10.1186/s12943-017-0648-1) | Abstract ORCID License | 211.37 | 657 |
| 50 | — (10.1186/1476-4598-3-26) | Abstract References ORCID License | 210.72 | 127 |